The increasing incidence of genetic and rare diseases is a major factor driving revenue growth in the Antisense ...

UCB’s continued commitment to leading research aimed at improving treatment outcomes for people living with neurological conditions.Data include the use of FINTEPLA®▼ (fenfluramine)1 in Dravet ...

About this study The purpose of this study is to assess the effect of zorevunersen to reduce the frequency of major motor seizures in patients with DS. Major motor seizures are defined as the ...

While Harmony Biosciences HRMY may not be a typical cannabis stock involved in cultivation, processing, or sales of marijuana products, it is among the few companies evaluating an investigational ...